You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Treatment-Experienced

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Coronary Syndrome Trial (A-Phase: tirofiban; Z-Phase simvastatin, Duration of Treatment: A-Phase: minimum suggested 48

Completed
  • Acute Coronary Syndrome
  • A-Phase: tirofiban; Z-Phase simvastatin
  • +4 more
  • (no location specified)
Feb 7, 2022

Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin)

Completed
Has Results
  • Chronic Hepatitis C Infection
  • (no location specified)
Jul 8, 2021

HIV Trial in Brazil, South Africa, United States (Etravirine (ETR))

Completed
Has Results
  • HIV Infections
  • Etravirine (ETR)
  • Miami, Florida
  • +10 more
Oct 29, 2021

HIV Trial in United States (Mycophenolate mofetil, Amdoxovir)

Completed
  • HIV Infections
  • Los Angeles, California
  • +16 more
Oct 28, 2021

Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)

Recruiting
  • Colorectal Adenocarcinoma
  • Oesogastric
  • Besançon, France
  • +10 more
Jan 28, 2022

HIV-1-infection Trial in Worldwide (Oral Lenacapavir, Oral Lenacapavir Placebo, Subcutaneous Lenacapavir)

Active, not recruiting
Has Results
  • HIV-1-infection
  • Oral Lenacapavir
  • +4 more
  • Los Angeles, California
  • +74 more
Oct 17, 2022

HIV, AIDS Trial in China (albuvirtide, lopinavir-ritonavir, tenofovir)

Completed
  • HIV Infections
  • AIDS
  • Beijing, Beijing, China
  • +11 more
Sep 28, 2021

HIV Trial in Puerto Rico, United States (ibalizumab, Optimized Background Regimen)

Completed
Has Results
  • HIV
  • Long Beach, California
  • +31 more
Feb 18, 2021

Primary Immunodeficiency Trial in United States (IGSC 20% daily push versus every 2 weeks pump, IGSC 20% daily push versus once

Withdrawn
  • Primary Immunodeficiency
  • IGSC 20% daily push versus every 2 weeks pump
  • +3 more
  • South Bend, Indiana
  • +3 more
Apr 8, 2020

HIV Trial in United States (SCH-D (vicriviroc), Placebo)

Completed
  • HIV Infections
  • SCH-D (vicriviroc)
  • Placebo
  • Los Angeles, California
  • +29 more
Oct 28, 2021

HIV-1 Infection Trial in Worldwide (ISL, DOR, DOR/ISL)

Active, not recruiting
  • HIV-1 Infection
  • Birmingham, Alabama
  • +97 more
Jan 5, 2023

Hepatitis B, Liver Fibrosis Trial in Guangzhou (Tenofovir Disoproxil Fumarate, PEG-Interferon alfa 2a)

Recruiting
  • Hepatitis B
  • Liver Fibrosis
  • Tenofovir Disoproxil Fumarate
  • PEG-Interferon alfa 2a
  • Guangzhou, Guangdong, China
    Third Affiliated Hospital of Sun Yat-sen University
Jan 17, 2020

Melanoma Trial in Beijing (HX008, LP002)

Unknown status
  • Melanoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Feb 12, 2021

(Lopinavir/Ritonavir + LamivudinE) in Treatment-Experienced HIV

Completed
Has Results
  • HIV-1 Infection
  • (no location specified)
May 22, 2019

Chronic Hepatitis C Virus Infection Trial in Bani Sweif (SOF/SMV/DCV/RBV)

Completed
  • Chronic Hepatitis C Virus Infection
  • Bani Sweif, Egypt
    Health Administration at Beni-Seuf
May 10, 2020

Hepatitis B, Liver Fibrosis Trial in Guangzhou (Tenofovir Disoproxil Fumarate, Peginterferon Alfa-2a, Peginterferon Alfa-2b)

Unknown status
  • Hepatitis B
  • Liver Fibrosis
  • Tenofovir Disoproxil Fumarate
  • +2 more
  • Guangzhou, Guangdong, China
    Third Affiliated Hospital of Sun Yat-sen University
May 20, 2019

Precocious Puberty Trial in Shanghai (ziyinxiehuo Granules, zishenqinggan Granules)

Completed
  • Precocious Puberty
  • ziyinxiehuo Granules
  • zishenqinggan Granules
  • Shanghai, Shanghai, China
    Department of Chinses Traditional Medcine； Children Hospital of
Nov 27, 2019

Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Fayetteville, Arkansas
  • +22 more
Jun 29, 2021

Depression Mild, Depression Moderate Trial in Marburg (Behavioral Activation, Mindfulness and Gratitude, Combination of

Completed
  • Depression Mild
  • Depression Moderate
  • Behavioral Activation
  • +2 more
  • Marburg, Germany
    Philipps University
Oct 9, 2023

Ibalizumab in Trials vs. Other Regimens in OPERA

Active, not recruiting
  • HIV-1-infection
  • Durham, North Carolina
    Epividian
Aug 8, 2022

Glycogen Storage Disease Type II Infantile Onset Trial in Gainesville (Cipaglucosidase alfa (ATB200), Miglustat (AT2221))

Recruiting
  • Glycogen Storage Disease Type II Infantile Onset
  • Gainesville, Florida
    University of Florida Clinical Research Center
Jan 18, 2023

Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Tucson, Arizona
  • +147 more
Jan 24, 2023

Chronic HCV Infection Trial in China, Korea, Republic of, Taiwan (LDV/SOF)

Completed
Has Results
  • Chronic HCV Infection
  • Beijing, China
  • +44 more
Feb 18, 2020

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022

Hepatitis C, Chronic Trial in Worldwide (AL-335, Odalasvir, Simeprevir)

Completed
Has Results
  • Hepatitis C, Chronic
  • Antwerpen, Belgium
  • +27 more
Nov 19, 2019